Skip to main content

Prevention

Imagine a world where diseases are detected before they even emerge – a world where individual health risks are detected early, enabling precise interventions to maintain health. This is exactly what we are working on at Helmholtz Munich. Our research is unlocking new dimensions in prevention: we decode genetic predispositions, analyze the impact of lifestyle and environment, and harness artifical intelligence to predict diseases and their progression. We are developing cutting-edge technologies to visualize hidden risks at the deepest molecular level. Our goal? To prevent diseases before they arise and, with the power of AI and bioengineering, shape a healthier future for all.

Imagine a world where diseases are detected before they even emerge – a world where individual health risks are detected early, enabling precise interventions to maintain health. This is exactly what we are working on at Helmholtz Munich. Our research is unlocking new dimensions in prevention: we decode genetic predispositions, analyze the impact of lifestyle and environment, and harness artifical intelligence to predict diseases and their progression. We are developing cutting-edge technologies to visualize hidden risks at the deepest molecular level. Our goal? To prevent diseases before they arise and, with the power of AI and bioengineering, shape a healthier future for all.

"An apple a day... That's not enough!" - Interview with Helmholtz Munich CEO Prof. Matthias Tschöp

How do we define health and disease, and how are breakthroughs in AI and bioengineering reshaping disease prevention?

 

Our Vision

Preventive Check-Ups with AI

"In the future, doctor visits will offer unprecedented certainty. AI-powered preventive screenings will detect even the smallest anomalies that might go unnoticed otherwise. A single comprehensive check-up will identify potential health risks before they can develop into serious conditions. Additionally, much of the prevention will occur at home, with sensors and handheld devices continuously monitoring health and allowing for early intervention."

Visit Julia's page
Julia Schnabel

Prof. Julia Schnabel

Director at the Institute of Machine Learning in Biomedical Imaging

Accelerate Disease Prevention with AI and Bioengineering

"Our goal is to use cutting-edge technologies in sensing, genetics, and machine learning to make early detection and prevention available at a new level for everyone, to accelerate it, and to make it more precise. Ideally, we want to detect and prevent diseases long before they manifest."

Visit Matthias' page
Matthias Tschöp

Prof. Matthias Tschöp

CEO at Helmholtz Munich

Overcome Reseach Gap

"Metabolic diseases such as obesity or diabetes often have their origin in childhood. However, children do not adequately benefit from research programs and clinical advance. We need to overcome this research gap to prevent obesity early on."

Visit Antje's page
Mitarbeiterin-/PI-Foto Antje Körner

Prof. Antje Körner

Head of Research Group Childhood Obesity and Metabolic Research at HI-MAG

Early Detection of Type 1 Diabetes in Children

“We aim to democratize access to early-detection tests for type 1 diabetes, thereby protecting affected children from serious metabolic complications. This goal can only be achieved through the inclusion of autoantibody tests into standard medical care."

Visist Anette's page
Anette G. Ziegler_158

Prof. Anette-Gabriele Ziegler

Director at the Institute of Diabetes Research

Research News

Our Core Facilities

At Helmholtz Munich, eight core facilities with cutting-edge technologies and outstanding expertise support more than 1,500 scientists in developing new solutions for disease prevention and personalized medicine.

Talk to our press office

Media Contact

COMS Communications & Strategic Relations